Topic
Topic
A new comparative analysis puts retifanlimab and avelumab side by side in metastatic Merkel cell carcinoma, sharpening first-line systemic therapy choices in this rare skin cancer.
A comparative analysis weighs retifanlimab against avelumab in metastatic Merkel cell carcinoma, sharpening checkpoint inhibitor…
Medscape's new clinician-facing analysis puts intratumoral immunotherapy under scrutiny, asking whether injecting skin tumors dir…
Medscape's new skill checkup walks clinicians through a BRAF wild-type metastatic melanoma case — the population where immunother…
Ovid has indexed a review titled 'The role of the microbiome in skin cancer development and treatment,' adding to an expanding li…
Chronic immune-related adverse events occur commonly after adjuvant anti–PD-1 therapy for melanoma, The ASCO Post reports, raisin…
Ling Chen and Zhu Shen critique the case-control design of the JAAD study separating progressive immunotherapy-related mucocutane…
Researcher Lisa Ebert will present new biomarker findings in melanoma immunotherapy at the SITC meeting, OncoDaily reports. Clini…
B cells play an important role in the antitumor immune response to melanoma, the American Association of Immunologists reports —…
A Cleveland Clinic case study tests immunotherapy before surgery in a 79-year-old with stage IIB melanoma, probing sequencing in…
